-
GEN – Genetic Engineering & Biotechnology News3 months agoHIV Remains Suppressed in Some Patients After Treatment Withdrawal
For millions of people with HIV (PWH), a daily regimen of medications is a lifelong necessity. If they stop taking antiretroviral therapy (ART), the virus usually...
-
GEN – Genetic Engineering & Biotechnology News3 months ago
Skin Regeneration Enabled by Embryonic Healing Mechanism in Mice
In a new study published in Cell titled, “Hyperinnervation inhibits organ-level regeneration in mammalian skin,” researchers from Harvard University reveal a method to fully regenerate skin by unblocking an embryonic...
-
STAT News – Biotech3 months agoSTAT+: This bill could make CVS choose between its stores and its pharmacy benefit manager
WOONSOCKET, R.I. — A proposal in the Tennessee legislature could force CVS Health to sever a core piece of its business model or exit the state entirely, and...
-
GEN – Genetic Engineering & Biotechnology News3 months ago
Aging Mice Share Features of Brain Network Decline with Humans
The human brain operates as a network of interconnected modules specialized for tasks that become less specialized as people age—a breakdown associated with memory loss and...
-
STAT News – Biotech3 months agoNIH grant terminations affected women scientists more than men, study finds
Academics have long referred to their field as a leaky pipeline — gradually bleeding researchers from marginalized communities as they progress through their careers. A new paper,...
-
Endpoints News3 months ago
Novartis to invest $480M in China following AstraZeneca and Lilly pledges
Novartis is the latest drugmaker to invest in its Chinese footprint, with a pledge of more than 3.3 billion yuan ($480 million) to bolster two manufacturing...
-
AI & Machine Learning in Biotechnology3 months agoSTAT+: The intersection of ‘Apprentice’ and the No Surprises Act
This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here. Spring break is here, and our family is road tripping to...
-
Biotech Industry Intelligence3 months ago
FDA posts photos of Indian drugmaking facility cited in warning letter
FDA posts photos of Indian drugmaking facility cited in warning letter
-
Fierce Biotech3 months ago
Aardvark halts trials of obesity candidate, putting entire pipeline on pause
The voluntary pause comes less than a month after Aardvark paused a phase 3 trial for a related asset due to cardiac concerns.
-
BioPharma Dive – AI / Data3 months agoApogee strengthens case for longer-lasting eczema drug
Company shares climbed by more than 20% on Phase 2 study results suggesting the therapy could provide sustained relief when administered once every three or six...
Laser‑Driven Phase Contrast Enhances Cryo‑EM Resolution of Small Proteins
STAT+: Updated: Tracking RFK Jr.’s promises to remake health in America
